John Pagel
Hematology & Oncology · Seattle, WANPI 1376633222
Payments from drug & device makers
Across 915 payments — averaging $6669.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$3.2M
- Gilead$961K
- Acerta Pharma LLC$780K
- AstraZeneca$270K
- Pharmacyclics LLC, An Abbvie Company$180K
- AbbVie$115K
- plus $637K from 17 others
Across 4 payments — averaging $401.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- F. Hoffmann-la Roche AG$1K
- AstraZeneca$524
- TG Therapeutics, Inc.$16
What the payments were for
- Consulting fees$121,24717%
- Speaking & faculty fees$540,45375%
- Travel & lodging$54,9688%
- Food & beverage$7,8971%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 13 | $3,159,213 |
| Gilead(2 entities) | 216 | $961,168 |
| Acerta Pharma LLC | 26 | $780,498 |
| AstraZeneca | 190 | $270,089 |
| Pharmacyclics LLC, An Abbvie Company | 81 | $179,615 |
| AbbVie | 47 | $115,085 |
| Incyte Corporation | 95 | $111,360 |
| Astrazeneca UK Limited | 16 | $97,100 |
| Seagen Inc. | 13 | $81,424 |
| Bristol Myers Squibb | 33 | $80,683 |
| Genentech, Inc. | 4 | $44,600 |
| Epizyme, Inc. | 40 | $42,263 |
| TG Therapeutics, Inc. | 25 | $41,975 |
| Beigene USA, Inc. | 28 | $41,303 |
| Takeda Pharmaceuticals U.S.A., Inc. | 24 | $34,296 |
| F. Hoffmann-la Roche AG | 5 | $25,619 |
| Verastem, Inc. | 18 | $13,357 |
| Adaptive Biotechnologies Corporation | 5 | $12,030 |
| Merck | 4 | $4,591 |
| Morphosys, US Inc. | 1 | $3,075 |
| Pfizer | 1 | $2,000 |
| Johnson & Johnson | 29 | $843 |
| Coherus Oncology, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,102,202 in reported general payments places this provider in the 95th percentile of 349 hematology & oncology providers in Washington.
Other hematology & oncology in Seattle
- Mazyar ShadmanSeattle$36.8M
- Ryan CassadaySeattle$22.7M
- John PesandoSeattle$15.7M
- Andrew CowanSeattle$15M
- Stephen SmithSeattle$12.6M
- Stephanie LeeSeattle$11.2M
- Sara HurvitzSeattle$10.9M
- Chaitra UjjaniSeattle$10.6M
- Lawrence FongSeattle$9.7M
- Cameron TurtleSeattle$8.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.